Status:
UNKNOWN
Protective Effect of Propofol Against Hemolysis in Patients Submitted to Gastroplasty
Lead Sponsor:
Centro Medico Campinas
Conditions:
Hemolysis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if propofol could protect erythrocytes by directly scavenging free radicals from the blood current and increasing resistance of their cell membranes in patien...
Eligibility Criteria
Inclusion
- patients between BMI 40-50 kg/m2
Exclusion
- patients with BMI under 40 kg/m2 and over 50 kg/m2
- alcohol users
- illicit-drug users
- patients in regular use of anti-depressants, proton bomb inhibitors or calcium canal blockers
- patients transfused either recently, during the intra-operative period or within 10 hours post-operative
- patients previously known to be hypersensitive to any drug that is used during the study
- patients with any psychiatric disorder or dementia
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2009
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00792779
Start Date
November 1 2008
End Date
June 1 2009
Last Update
November 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundação Centro Médico de Campinas
Campinas, São Paulo, Brazil, 13084-000